GlobeNewswire 13-Oct-2017 4:05 PM
SAN DIEGO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 11:30 a.m. PT on Wednesday, October 18, at the BIO Investor Forum Conference (San Francisco October 17-18). A webcast of the companys presentation will be available live through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.
About Vical Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.
Contact: Tony Ramos(858) 646-1127Website:www.vical.com
Source: Vical Incorporated